{Reference Type}: Journal Article
{Title}: Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors.
{Author}: Daoud D;Chacon Alberty L;Wei Q;Hochman Mendez C;Virk MHM;Mase J;Jindra P;Cusick M;Choi H;Debolske N;Sampaio LC;Taylor DA;Loor G;
{Journal}: J Thorac Dis
{Volume}: 13
{Issue}: 6
{Year}: Jun 2021
{Factor}: 3.005
{DOI}: 10.21037/jtd-20-3564
{Abstract}: <B>UNASSIGNED: </B>Primary graft dysfunction (PGD) is the most important determinant of morbidity and mortality after lung transplantation, but its definition has evolved over the past decade. The implications of this refinement in clinical definition have not been evaluated. In this single-center study, we compared PGD incidence, risk factors, and outcomes using the 2005 and the updated-2016 International Society of Heart and Lung Transplantation guidelines for PGD grading in lung transplant patients.<BR><B>UNASSIGNED: </B>In this retrospective study, we extracted data from the medical records of 127 patients who underwent lung transplantation between 1/1/2016-12/31/2018. PGD was defined as PGD3 present at 48 and/or 72 hours post-reperfusion. We used the 2005 and the updated 2016 guidelines to assess clinical risk factors, outcomes, and baseline biomarkers for PGD.<BR><B>UNASSIGNED: </B>On the basis of the 2016 and 2005 guidelines, we identified PGD in 37% and 26% of patients, respectively. PGD was significantly associated with extracorporeal life support, large body mass index, and restrictive lung disease using the 2016 but not the 2005 guidelines. Based on the 2016 guidelines, pretransplant levels of several biomarkers were associated with PGD; using the 2005 guidelines, only increased interleukin-2 levels were significantly associated with PGD. No preoperative biomarkers were associated with PGD using either guidelines after adjusting for clinical variables. Postoperative morbidity and 1-year mortality were similar regardless of guidelines used.<BR><B>UNASSIGNED: </B>Our findings suggest that refinements in the PGD scoring system have improved the detection of graft injury and associated risk factors without changing its ability to predict postoperative morbidity and mortality.